Cognitive recovery by chronic activation of the large-conductance calcium-activated potassium channel in a mouse model of Alzheimer's disease

Neuropharmacology

Volumn 92, Issue , 2015, Pages 8-15

  Wang, Li ^a,b   Kang, Huicong ^a,c   Li, Yongzhi ^a,d   Shui, Yuan ^a,b   Yamamoto, Ryo ^a   Sugai, Tokio ^a   Kato, Nobuo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Excitability Synaptic plasticity; Large conductance calcium activated potassium channels; Learning and memory

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CHARYBDOTOXIN; ISOPIMARIC ACID; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); CARBOXYLIC ACID; NEUROTOXIN; PEPTIDE FRAGMENT; PHENANTHRENE DERIVATIVE;

3XTG MOUSE; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN SLICE; CELLULAR DISTRIBUTION; CHRONIC DRUG ADMINISTRATION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CONVALESCENCE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPAL CA1 REGION; LONG TERM POTENTIATION; MALE; MEMORY DISORDER; MORRIS WATER MAZE TEST; MOUSE; MOUSE MODEL; NERVE CELL EXCITABILITY; NEUROPSYCHOLOGICAL TEST; NONHUMAN; OSMOTIC PUMP; PATTERN RECOGNITION; PROTEIN CONTENT; PROTEIN LOCALIZATION; PYRAMIDAL NERVE CELL; SPATIAL MEMORY; SPIKE WAVE; SYNAPTIC TRANSMISSION; TASK PERFORMANCE; TREATMENT OUTCOME; ANIMAL; C57BL MOUSE; COGNITION DISORDERS; COMPLICATION; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IN VITRO STUDY; METABOLISM; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; RECOGNITION; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CA1 REGION, HIPPOCAMPAL; CARBOXYLIC ACIDS; CHARYBDOTOXIN; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION; HUMANS; IN VITRO TECHNIQUES; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; LONG-TERM POTENTIATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUROTOXINS; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; PHENANTHRENES; RECOGNITION (PSYCHOLOGY);

EID: 84921022188     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.12.033     Document Type: Article

References (38)

1. D.L. Brody, and D.M. Holtzman Active and passive immunotherapy for neurodegenerative disorders Annu. Rev. Neurosci. 31 2008 175 193
2. M.A. Busche, G. Eichhoff, H. Adelsberger, D. Abramowski, K.H. Wiederhold, C. Haass, M. Staufenbiel, A. Konnerth, and O. Garaschuk Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease Science 321 2008 1686 1689
3. X.B. Chang, and A.K. Stewart What is the functional role of the thalidomide binding protein cereblon? Int. J. Biochem. Mol. Biol. 2 2011 287 294
4. J.R. Cirrito, K.A. Yamada, M.B. Finn, R.S. Sloviter, K.R. Bales, P.C. May, D.D. Schoepp, S.M. Paul, S. Mennerick, and D.M. Holtzman Synaptic activity regulates interstitial fluid amyloid-β levels in vivo Neuron 48 2005 913 922
5. H. Crystal, D. Dickson, P. Fuld, D. Masur, R. Scott, M. Mehler, J. Masdeu, C. Kawas, M. Aronson, and L. Wolfson Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease Neurology 38 1988 1682 1687
6. W. Du, J.F. Bautista, H. Yang, A. Diez-Sampedro, S.A. You, and L. Wang Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder Nat. Genet. 37 2005 733 738
7. E.S. Faber, and P. Sah Ca2+-activated K+ (BK) channel inactivation contributes to spike broadening during repetitive firing in the rat lateral amygdala J. Physiol. Lond. 552 2003 483 497
8. A.M. Fagan, D. Head, A.R. Shah, D. Marcus, M. Mintun, J.C. Morris, and D.M. Holtzman Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly Ann. Neurol. 65 2009 176 183
9. F. Ferreri, F. Pauri, P. Pasqualetti, R. Fini, G. Dal Forno, and P.M. Rossini Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation study Ann. Neurol. 53 2003 102 108
10. K.B.J. Franklin, and G. Paxinos The Mouse Brain in Stereotaxic Coordinates third ed. 2007 Academic Press New York
11. M. Goedert, and M.G. Spillantini A century of Alzheimer's disease Science 314 2006 777 781
12. G.K. Gouras, J. Tsai, J. Naslund, B. Vincent, M. Edgar, F. Checler, J.P. Greenfield, V. Haroutunian, J.D. Buxbaum, H. Xu, P. Greengard, and N.R. Relkin Intraneuronal Aβ42 accumulation in human brain Am. J. Pathol. 156 2000 15 20
13. C. Haass, and D.J. Selkoe Soluble protein oligomers in neuro-degeneration: lessons from the Alzheimer's amyloid beta-peptide Nat. Rev. Mol. Cell Biol. 8 2007 101 112
14. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
15. J.J. Higgins, J. Hao, B.E. Kosofsky, and A.M. Rajadhyaksha Dysregulation of large-conductance Ca2+-activated K+ channel expression in nonsyndromal mental retardation due to a cereblon p.R419X mutation Neurogenetics 9 2008 219 223
16. C. Holmes, D. Boche, D. Wilkinson, G. Yadegarfar, V. Hopkins, A. Bayer, R.W. Jones, R. Bullock, S. Love, J.W. Neal, E. Zotova, and J.A. Nicoll Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial Lancet 372 2008 216 223
17. M. Inghilleri, A. Conte, V. Frasca, N. Scaldaferri, F. Gilio, M. Santini, G. Fabbrini, M. Prencipe, and A. Berardelli Altered response to rTMS in patients with Alzheimer's disease Clin. Neurophysiol. 117 2006 103 109
18. Y. Isomura, and N. Kato Action potential-induced dendritic calcium dynamics correlated with synaptic plasticity in developing hippocampal pyramidal cells J. Neurophysiol. 82 1999 1993 1999
19. F. Kamenetz, T. Tomita, H. Hsieh, G. Seabrook, D. Borchelt, T. Iwatsubo, S. Sisodia, and R. Malinow APP processing and synaptic function Neuron 37 2003 925 937
20. W.E. Klunk, H. Engler, A. Nordberg, Y. Wang, G. Blomqvist, D.P. Holt, M. Bergström, I. Savitcheva, G.F. Huang, S. Estrada, B. Ausén, M.L. Debnath, J. Barletta, J.C. Price, J. Sandell, B.J. Lopresti, A. Wall, P. Koivisto, G. Antoni, C.A. Mathis, and B. Langström Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B Ann. Neurol. 55 2004 306 319
21. F.M. LaFerla, K.N. Green, and S. Oddo Intracellular amyloid-β in Alzheimer's disease Nat. Rev. Neurosci. 8 2007 499 509
22. R. Lu, A. Alioua, Y. Kumar, M. Eghbali, E. Stefani, and L. Toro MaxiK channel partners: physiological impact J. Physiol. 570 2006 65 72
23. R. Minkeviciene, S. Rheims, M.B. Dobszay, M. Zilberter, J. Hartikainen, L. Fülöp, B. Penke, Y. Zilberter, T. Harkany, A. Pitkänen, and H. Tanila Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy J. Neurosci. 29 2009 3453 3462
24. M.A. Mintun, G.N. Larossa, Y.I. Sheline, C.S. Dence, S.Y. Lee, R.H. Mach, W.E. Klunk, C.A. Mathis, S.T. DeKosky, and J.C. Morris [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease Neurology 67 2006 446 452
25. H. Moreno, E. Yu, G. Pigino, A.I. Hernandez, N. Kim, J.E. Moreira, M. Sugimori, and R.R. Llinás Synaptic transmission block by presynaptic injection of oligomeric amyloid beta Proc. Natl. Acad. Sci. U. S. A. 106 2009 5901 5906
26. J. Morris, and J. Price Pathologic correlates of nondemented aging, mild cognitive impairment, and early stage Alzheimer's disease J. Mol. Neurosci. 17 2001 101 118
27. S. Oddo, A. Caccamo, J.D. Shepherd, M.P. Murphy, T.E. Golde, R. Kayed, R. Metherate, M.P. Mattson, Y. Akbari, and F.M. LaFerla Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Aβ and synaptic dysfunction Neuron 39 2003 409 421
28. J.J. Palop, J. Chin, E.D. Roberson, J. Wang, M.T. Thwin, N. Bien-Ly, J. Yoo, K.O. Ho, G.Q. Yu, A. Kreitzer, S. Finkbeiner, J.L. Noebels, and L. Mucke Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease Neuron 55 2007 697 711
29. A. Perretti, D. Grossi, N. Fragassi, B. Lanzillo, M. Nolano, A.I. Pisacreta, G. Caruso, and L. Santoro Evaluation of the motor cortex by transcranial magnetic stimulation in patients with Alzheimer disease J. Neurol. Sci. 135 1996 31 37
30. R.J. Perrin, A.M. Fagan, and D.M. Holtzman Multi-modal techniques for diagnosis and prognosis of Alzheimer's disease Nature 461 2009 916 922
31. Y. Sakagami, K. Yamamoto, S. Sugiura, K. Inokuchi, T. Hayashi, and N. Kato Essential roles of Homer-1a in homeostatic regulation of pyramidal cell excitability: a possible link to clinical benefits of electroconvulsive shock Eur. J. Neurosci. 21 2005 3229 3239
32. D. Schenk, R. Barbour, W. Dunn, G. Gordon, H. Grajeda, T. Guido, K. Hu, J. Huang, K. Johnson-Wood, and K. Khan Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
33. A.M. Simón, L. Schiapparelli, P. Salazar-Colocho, Mar Cuadrado-Tejedor, L. Escribano, R.L. de Maturana, J. Del Río, A. Pérez-Mediavilla, and D. Frechilla Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Aβ levels Neurobiol. Dis. 33 2009 369 378
34. P. Sun, F. Wang, L. Wang, Yu Zhang, R. Yamamoto, T. Sugai, Q. Zhang, Z. Wang, and N. Kato Increase in cortical pyramidal cell excitability accompanies depression-like behavior in mice: a transcranial magnetic stimulation study J. Neurosci. 31 2011 16464 16472
35. T. Sunderland, G. Linker, N. Mirza, K.T. Putnam, D.L. Friedman, L.H. Kimmel, J. Bergeson, G.J. Manetti, M. Zimmermann, B. Tang, J.J. Bartko, and R.M. Cohen Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease JAMA 289 2003 2094 2103
36. K. Ueda, S. Shinohara, T. Yagami, K. Asakura, and K. Kawasaki Amyloid beta protein potentiates Ca2+ influx through L-type voltage- sensitive Ca2+ channels: a possible involvement of free radicals J. Neurochem. 68 1997 265 271
37. C. Velázquez-Marrero, P. Wynne, A. Bernardo, S. Palacio, G. Martin, and S.N. Treistman The relationship between duration of initial alcohol exposure and persistence of molecular tolerance is markedly nonlinear J. Neurosci. 31 2011 2436 2446
38. K. Yamamoto, Y. Ueta, L. Wang, R. Yamamoto, N. Inoue, K. Inokuchi, A. Aiba, H. Yonekura, and N. Kato Suppression of a neocortical potassium channel activity by intracellular amyloid β and its rescue with Homer1a J. Neurosci. 31 2011 11100 11109